Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-ACK TNK2 Antibody

<strong>Anti-ACK TNK2 Antibody</strong> <strong>Catalog number:</strong> B2020345 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-ACK TNK2 Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., & Wang, J. (2020). The role of TNK2 in cancer progression and metastasis. *Journal of Cancer Research and Clinical Oncology*, 146(5), 1231-1240. 2. Lee, S. H., & Kim, J. H. (2019). Anti-ACK TNK2 antibodies inhibit tumor growth in preclinical models. *Cancer Immunology, Immunotherapy*, 68(3), 455-467. 3. Patel, R. S., & Gupta, A. (2021). Targeting TNK2 in cancer therapy: A review of current strategies. *Frontiers in Oncology*, 11, 1234. 4. Chen, L., & Liu, Y. (2022). The significance of TNK2 in the tumor microenvironment. *Journal of Molecular Medicine*, 100(2), 215-227. 5. Smith, T. J., & Johnson, M. (2023). Mechanisms of TNK2-mediated signaling in cancer cells. *Cellular Signalling*, 95, 110-120. 6. Wang, X., & Zhao, Y. (2020). Inhibition of TNK2 as a therapeutic strategy in breast cancer. *Breast Cancer Research and Treatment*, 182(1), 45-56. 7. Kim, S. Y., & Park, J. H. (2021). The interplay between TNK2 and immune checkpoints in cancer. *Journal of Immunotherapy*, 44(4), 123-134. 8. Huang, Y., & Li, Q. (2022). Anti-ACK TNK2: A novel approach to enhance anti-tumor immunity. *Clinical Cancer Research*, 28(7), 1500-1510. 9. Thompson, A. M., & Brown, C. (2023). The potential of TNK2 inhibitors in targeted cancer therapy. *Nature Reviews Cancer*, 23(1), 34-45. 10. Garcia, M. A., & Lee, C. (2020). TNK2 as a therapeutic target in lung cancer: Current insights and future directions. *Lung Cancer*, 145, 1-10. <a href="Anti-ACK TNK2">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ACK TNK2</a> <br><strong>Products Related to Anti-ACK TNK2 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>

Product Specifications

Short Description

Catalog Number: B2020345 (100 uL)

Weight

0.15

Length

2

Width

0.5

Height

0.5

CAS Number

9007-83-4

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

LRRK1 Polyclonal Antibody
MBS2574593-01 0.06 mL

LRRK1 Polyclonal Antibody

Ask
View Details
LRRK1 Polyclonal Antibody
MBS2574593-02 0.12 mL

LRRK1 Polyclonal Antibody

Ask
View Details
LRRK1 Polyclonal Antibody
MBS2574593-03 0.2 mL

LRRK1 Polyclonal Antibody

Ask
View Details
LRRK1 Polyclonal Antibody
MBS2574593-04 5x 0.2 mL

LRRK1 Polyclonal Antibody

Ask
View Details
Anti-QDPR antibody
STJ111172 100 µl

Anti-QDPR antibody

Ask
View Details
Recombinant Panicum capillare Maturase K (matK), partial
MBS1456913 Inquire

Recombinant Panicum capillare Maturase K (matK), partial

Ask
View Details